Welcome to LookChem.com Sign In|Join Free

CAS

  • or

1063712-33-3

Post Buying Request

1063712-33-3 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

1063712-33-3 Usage

Structure

Cyclic organic compound with a dioxolane ring and substituents bromine and chlorine on the phenyl ring

Usage

Building block in the synthesis of various pharmaceuticals and agrochemicals

Biological activities

Antibacterial and antifungal properties

Potential applications

Herbicide, medicine, agriculture, and materials science.

Check Digit Verification of cas no

The CAS Registry Mumber 1063712-33-3 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,0,6,3,7,1 and 2 respectively; the second part has 2 digits, 3 and 3 respectively.
Calculate Digit Verification of CAS Registry Number 1063712-33:
(9*1)+(8*0)+(7*6)+(6*3)+(5*7)+(4*1)+(3*2)+(2*3)+(1*3)=123
123 % 10 = 3
So 1063712-33-3 is a valid CAS Registry Number.

1063712-33-3SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 17, 2017

Revision Date: Aug 17, 2017

1.Identification

1.1 GHS Product identifier

Product name 2-(4-bromo-3-chlorophenyl)-1,3-dioxolane

1.2 Other means of identification

Product number -
Other names -

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:1063712-33-3 SDS

1063712-33-3Relevant articles and documents

INHIBITORS OF MTOR-MEDIATED INDUCTION OF AUTOPHAGY

-

Paragraph 088, (2021/04/30)

The invention provides amides that inhibit apoptosis or induce autophagy through mTOR-mediated induction of autophagy, or inhibit a related disease such as cerebral ischemia/reperfusion or neurodegenerative diseases, including corresponding sulfonamides, and pharmaceutically acceptable salts, hydrates and stereoisomers thereof. The compounds are employed in pharmaceutical compositions, and methods of making and use, including treating a person in need thereof with an effective amount of the compound or composition, and detecting a resultant improvement in the person's health or condition.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 1063712-33-3